Can Epigral's Specialty Chemical Expansion Drive Revenue Mix to 70% by FY28?
India, Oct. 2 -- The shares of this small cap company majorly engaged in the business of manufacturing chemicals which includes derivatives, speciality chemicals, and many more were in focus after the management targets 70% speciality chemicals revenue target.
With the market capitalization of Rs. 4,273 Crores, the shares of Epigral Ltd were trading at around Rs.991 per share which is 44 percent discount from its 52 week high of Rs. 1771 per share and is trading at a P/E of 15.7 whereas industry P/E stands at 28.6.
From Chlor-Alkali to Higher-Value Products:
Epigral is gradually changing the composition of its business by increasing the contribution of derivatives and specialty chemicals. In FY26, derivatives and specialty chemicals ...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.